| |
What is on the Horizon for the Use of (CAR)T cell Immunotherapy in Resistant/Refractory Diffuse Large B-Cell Lymphoma? |
, , , , , |
|
On-Demand Webcast |
| |
Treatment Strategies and Guideline Recommendations for Newly-diagnosed Multiple Myeloma |
, , , , , |
|
On-Demand Webcast |
| |
Clinical Advances in the Diffuse Large B-Cell Lymphoma Therapeutic Landscape: A Focus on Relapsed/Refractory Treatment Strategies |
, , , , , |
|
On-Demand Webcast |
| |
Incorporating Targeted Therapies into Care for Chronic Lymphocytic Leukemia and Small Lymphocytic Leukemia |
, , , , , |
|
On-Demand Webcast |
| |
Advancing the Current Treatment Paradigm for MDS: Monoclonal Antibodies and Targeted Immune Therapy |
, , , , , |
|
On-Demand Webcast |
| |
HHT Guidelines Updates and Advancements in Research for the Treatment of PAVMs |
, , , , |
Vascular, Radiology |
On-Demand Webcast |
| |
Addressing Persistent Myths and Misconceptions in Tardive Dyskinesia |
, , , , |
Psychiatry, Neurology |
Satellite Symposia |
| |
Antibody Therapies: A New Path Forward in the Treatment of Relapsed/Refractory Multiple Myeloma |
, , , , , |
Oncology |
On-Demand Webcast |
| |
Urothelial Cancer Clinical Pathways: Leveraging Recent Advances and Evolving Management Strategies to Optimize Care and Address Unmet Needs |
, , , , , |
Oncology |
On-Demand Webcast |
| |
Metastatic Breast Cancer: Optimizing Care Through Clinical Pathways |
, , , , , |
Oncology |
On-Demand Webcast |
